PuSH - Publication Server of Helmholtz Zentrum München

Specific and redundant functions of histone deacetylases in regulation of cell cycle and apoptosis.

Cell Cycle 3, 115-117 (2004)
Publ. Version/Full Text DOI
Closed
Open Access Green as soon as Postprint is submitted to ZB.
Inappropriate control of expression of genetic information is the cause of many forms ofcancer. Aberrant transcriptional repression by recruitment of histone deacetylases (HDACs) isa key step in pathogenesis of myeloid leukemia. We recently reported that development ofcolonic cancer involves alterations in the transcriptional repression machinery by increasedexpression of HDAC 2 upon loss of the APC tumor suppressor. Increased expression ofHDAC 2 is essential for prevention of apoptosis of HT-29 colonic cancer cells. We nowdiscuss whether HDAC 2 also plays a role for aberrant cell cycle regulation and expression ofthe p21Cip/Waf cell cycle inhibitor. Whereas inhibition of HDACs by valproic acid ortrichostatin A increases p21 expression, selective interference with HDAC 2 by siRNAtransfection or reconstitution of wildtype APC does not affect p21 expression. Likewise,treatment of HT-29 cells with the HDAC inhibitor valproic acid leads to a moderate inhibitionof cell cycle progression in the G1 phase whereas interference with HDAC2 expression doesnot. Thus, HDAC 2 appears to serve a preferential role in the prevention of apoptosis and notin cell cycle control similar to the specific importance of HDAC 1 for cell cycle regulation orHDAC 9 for the stress response of the heart.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
0.200
0.000
33
37
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords cell cycle; apoptosis; cancer treatment; histone deacetylases; HDAC inhibitors; colon cancer; myeloid leukemia
Language english
Publication Year 2004
HGF-reported in Year 0
ISSN (print) / ISBN 1538-4101
e-ISSN 1551-4005
Journal Cell Cycle
Quellenangaben Volume: 3, Issue: 10, Pages: 115-117 Article Number: , Supplement: ,
Publisher Landes Bioscience
Reviewing status Peer reviewed
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Enabling and Novel Technologies
PSP Element(s) G-505200-001
Erfassungsdatum 2004-10-29